chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pt recvd vax & c/o numbness & tingling on left side of body; also dropping of L side of her mouth; examined by MD; given meds;
Patient experienced a rash at site of injection. Red light rash occurred 1-2 days after receiving the vaccine around the injection site.
pain in my injection arm; migraine; felt Disoriented; couldn't walk; my lower back is killing me like needles are poking in my back and coming around the sides and up to around my ribcage on both sides; short of breath; My legs wouldn't hold me up; I have random pain from the tip of my toes to the top of my head.; This is a spontaneous report from a contactable consumer (patient). A 48-Years-old male patient received second dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, on an unspecified date (age at vaccination: 48 years), as dose 2, single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, on an unspecified date, as dose 1, single dose for COVID-19 immunization. The patient had a reaction on 29Apr2021 after receiving his 2nd Pfizer vaccine dose. The patient stated, "no reactions to the 1st vaccine dose." The patient stated that, "he woke up at 3am with seeing pain in his injection arm, like a spasm. When he opened his eyes, there was a bright light in his head, like a migraine." He felt disoriented and couldn't walk or bear weight. His legs wouldn't hold him up and he had random pain from the tip of his toes to the top of his head. His legs were jumping on him like banging on the wall. Right now, his lower back was killing him like needles were poking in his back and coming around the sides and up to around his ribcage on both sides. BP was good. He was short of breath. The patient asked could he take any pain meds. The patient underwent lab test and procedure included body temperature 99.0 and pulse was high on 29Apr2021. Outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
I had my 2nd Pfizer covid vaccine on 8/25/2021 at 1pm. That evening I had severe whole left arm pain, where I had had my injection, epigastric pain, followed by mid sternum chest pain and severe chills that lasted until 2am. At 5am I had premature rupture of membranes I was 33weeks+5days pregnant. My ob delayed labour until I had received my steroid shots to help baby's lungs mature quickly and ensure I get to 34 weeks for delivery. As soon as I got 34 weeks, and I begun being induced for labour, I developed severe pre eclampsia which had not been noticed prior. I had to be placed on a magnesium drip to prevent seizures as my blood pressure was that high. Note that prior to receiving the vaccine, I had had my ob office visit the week before for my usual check with no pre eclampsia symptoms.
My arm is very sore; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details provided were as follows: Age at vaccination was not reported. The age group was selected as adult as per vaccine indication. The patient received Shingrix shot on an unknown date and experience pain in arm. The patient stated that he/she could not take ibuprofen. It was not red or swollen.
13OCT97 soreness in legs, sl fever in area;15OCT rash on trunk;15OCT went to dermatologist was told this was a nl side effect for flu;dx cephalosporin;
Swelling below lt ear inc swelling daily w/tenderness; firmness all along jaw bone from ear to chin; redness & bruising like color;
Per patient report, she developed a pulmonary embolism approximately 10 days after receiving vaccine, which required hospitalization of one week.  We just learned of this issue on 12/22/2021
Strong metallic taste in mouth; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 07Apr2021 at 08:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included cholesterol high. The patient had no known allergies to medications, food or other products. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN), cetirizine hydrochloride (ZYRTEC) and pseudoephedrine hydrochloride (SUDAFED) from an unknown date, for unknown indication and unknown if ongoing. The patient did not receive any other medications within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 11Apr2021 at 18:00, the patient experienced strong metallic taste in mouth. The patient reported of strong metallic taste in mouth, the patient had shot on wednesday morning and taste appeared on sunday evening and had gone stronger on monday, as of tuesday that was still present. No therapeutic measures were taken as a result of reported event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event strong metallic taste in mouth was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Pt devel a fever following the 1st dose of MMR; No further details were provided;
Dysgeusia: a sweet, metallic taste in the mouth that started about 2 hours after the vaccine was administered. This effect lasted for about 3 hours and resolved on its own without intervention.
sore arm; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included pain in hip, arthritis (gave a cortisone shot), nerve damage, swelling of legs, swelling of feet, restless legs syndrome and difficulty sleeping. Previously administered products included Cortison.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.     Linked case(s) involving the same patient:  US2022AMR112120   Additional Information: GSK Receipt Date: 25-JUL-2022 Reporter's Comments: This case was reported by a consumer via interactive digital media. The reporter stated that in January 2018 he/she woke up with the most excruciating pain in his/her hip that he/she had ever experienced. The reporter stated that their rheumatologist thought it was their arthritis and gave a cortisone shot. The reporter stated that he/she did not break out until two weeks later down his/her leg. His/her life was changed. He/she had nerve damage, swelling in both feet and legs, restless leg syndrome and trouble sleeping. The reporter stated that he/she wish he/she had known about the vaccine before. The reporter stated that a small sacrifice of a sore arm. He/she have had his/her vaccine shots. The reporter stated his/her neighbor told that she had the shingles twice, so the reporter did not want to chance it. The reporter stated that he/she encourages anyone that has had the chicken pox, to go get the vaccine. Additional supportive information: No follow-up was possible as no contact details were available.; Sender's Comments:  US-GSK-US2022AMR112120:same report, other dose
Left are started to swell a week after administration. There was also a red spot at the site of administration.  The swelling started to go down the next morning and continued to decrease through the day
Dizziness; Nauseous; A little headache; Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), DIARRHOEA (Diarrhea), NAUSEA (Nauseous) and HEADACHE (A little headache) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension (Patient takes regular blood pressure pills.).    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced DIZZINESS (Dizziness), NAUSEA (Nauseous) and HEADACHE (A little headache). On an unknown date, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIZZINESS (Dizziness) and NAUSEA (Nauseous) was resolving, DIARRHOEA (Diarrhea) outcome was unknown and HEADACHE (A little headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: Additional initial document received
Stuffy Nose (After Second Shot); Cough (After Second Shot); Malaise (After Second Shot); Lack of Taste  (After Second Shot); Lack of Smell   (After Second Shot); Mild COVID-19 Disease (After Second Shot); This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (Stuffy Nose (After Second Shot)), COUGH (Cough (After Second Shot)), MALAISE (Malaise (After Second Shot)), AGEUSIA (Lack of Taste  (After Second Shot)) and ANOSMIA (Lack of Smell   (After Second Shot)) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Jun-2021, the patient experienced NASAL CONGESTION (Stuffy Nose (After Second Shot)), COUGH (Cough (After Second Shot)), MALAISE (Malaise (After Second Shot)), AGEUSIA (Lack of Taste  (After Second Shot)), ANOSMIA (Lack of Smell   (After Second Shot)) and COVID-19 (Mild COVID-19 Disease (After Second Shot)). On 12-Jul-2021, NASAL CONGESTION (Stuffy Nose (After Second Shot)), COUGH (Cough (After Second Shot)), MALAISE (Malaise (After Second Shot)), AGEUSIA (Lack of Taste  (After Second Shot)), ANOSMIA (Lack of Smell   (After Second Shot)) and COVID-19 (Mild COVID-19 Disease (After Second Shot)) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Jun-2021, SARS-CoV-2 test: Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.   No treatment information was provided.
Patient developed life threatening Crohn's Disease after this vaccine. For 2 years she was unable to function normally - incurred school, daily pain, hospitalized twice, searched for alternative medicine treatments, they found one that works now off allopathic drugs - functioning normal for most part! She is not getting chelation treatment for mercury toxicity related to all of her vaccines!! 2 years of pure hell for our family!!
This spontaneous report as received from a vaccine coordinator and refers to an unspecified patient of unknown age and gender. Information on medical history, past drugs, concurrent conditions were not reported. On 24-JUL-2017, the patient was vaccinated with PROQUAD, (lot # M048201, exp date: 05-JUN-2018, dose, frequency not reported) for prophylaxis. Concomitant therapy included sterile diluent (Merck injection, lot # N006322, Exp date: 11-JUL-2019). No adverse effects were reported. All adverse event fields apply to the patient. Temperature was 11 degree Celsius (C). Time frame was for a duration of 46 hours and 30 minutes. There was no previous temperature excursion. Data logger was involved. This case is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1707USA010634.
Mother called 2 days after immunizations listed were given. States child has Hx of eczema rash-mild, but noted some hive-like raised areas on skin over body. No breathing problems. Does itch. No new product use per parent. Mom gave BENADRYL on day 1 + day 2 and stated better when called on Day 2 after shots. Instructed to go to ER if breathing problems.
Within 2 days of receiving the shot, a rash began to develop. Being told a rash was a normal side effect, I thought nothing of it. It progressed to only get worse and more painful resulting in blisters that would pop and ooze in my armpit down my trunk/abdomen and my forearm. The outbreak lasted 6 weeks. Scars still remain
inability to urinate, inability to lift legs, lack of balance. Arachnoiditis in spine. clonus,leg switching. nerve damage. in hospital for 3 days on  2 separate occastions. steriod iv to reduce inflamation, slowing recovering over 8 weeks to date. could be 6 more months to 1 year for nerves to heal
This spontaneous report has been received from a nurse practitioner regarding a patient of unknown age and gender. The patient's concurrent condition, medical history and concomitant medications were not reported. On an unknown date, the patient was vaccinated VARIVAX dose 1, (dose, lot # and expiry date unknown). On 02-DEC-2013, the patient received improperly stored VARIVAX dose 2, from lot # H018451, expiry date 09-OCT-2014 (dose, vaccination site, route unknown). No adverse effects were reported. The reporter stated that inconsistencies in storage temperature were identified on extensive review and records. The reporter stated that vaccine was not thawed. The nurse practitioner reported that there was insufficient data to provide 100 percent assurance on vaccine stability. This is one of several reports received from the same reporter. Additional information has been requested.
Patient developed one singular area of urticaria approximately one hour after the vaccination and then developed an anaphylactoid reaction 3 days later including widespread urticaria and chest tightness.  She took OTC antihistamines and recovered 6 days after the vaccine.
Patient had uncontrollable shaking, high fever and was turning blue in color  / was rushed to ER at apx 6:20 PM/ he was stablized & transported to hospital.
Pt vaccinated with Meruvax II developed diarrhea stool culture positive for salmonella. Treated w/Ciporfloxacin. MD felt pt experience was unrelated to vacination w/Rubella.
to urgent care 8 days prior to hospitalization and diagnosed with COVID 19, When she presented to the ED, she c/o increased shortness of breath and decrease oxygen saturation with exertion.
Patient was given a Pfizer 1st dose instead of a Moderna 2nd dose. Patient is okay. Pharmacy did not administer a 2nd pfizer shot due to pt having 1 moderna and 1 pfizer shot.
First symptom was swelling of legs/feet on 10/30/2021.  This was followed by low-grade fever, some muscle aches, shortness of breath, increased heart rate.  Saw internist, PRIVACY, on 11/09/2021 and she ordered ultrasound of legs and bloodwork.  Bloodwork from 11/11/2021 came back 11/12/2021 indicating hyperthyroidism.  Heart rate increased and patient concerned that atrial fibrillation may develop.  Went to a local Hospital ER on 11/14/2021.  No atrial fibrillation but cardiac enzyme troponin was borderline elevated.  Rx given of propanolol to decrease heart rate and thyroid activity.  Admitted.  Follow-up troponin in hospital was normal.  Thyroid and heart ultrasounds and radioiodine update and scan performed while in hospital and after discharge on 11/15/2021.  Graves Disease diagnosed and methimazole prescribed on 11/22/2021.
Flashes of light in the eyes; Continuous headache; This spontaneous case was reported by a patient and describes the occurrence of PHOTOPSIA (Flashes of light in the eyes) and HEADACHE (Continuous headache) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 062G20A, 015M20A and 062G20A) for COVID-19 prophylaxis.    Co-suspect product included non-company product INFLUENZA VACCINE for an unknown indication.    The patient's past medical history included COVID-19 (The patient was not hospitalized due to COVID-19. No treatment received.) on 01-Aug-2021 and Stent placement (has 3 stints). Concurrent medical conditions included Diabetes, Sleep apnea, Blood pressure high, Leukemia, Immunocompromised and House dust mite allergy (postnasal drip). Concomitant products included INSULIN GLARGINE (LANTUS), INSULIN ASPART (NOVOLOG), EMPAGLIFLOZIN (JARDIANCE), PANTOPRAZOLE, MONTELUKAST, SITAGLIPTIN PHOSPHATE (JANUVIA), AZILSARTAN MEDOXOMIL, CHLORTALIDONE (EDARBYCLOR), EZETIMIBE, FENOFIBRATE and POTASSIUM for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On 21-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On 21-Oct-2021, the patient received dose of INFLUENZA VACCINE (unknown route) 1 dosage form. On an unknown date, the patient experienced PHOTOPSIA (Flashes of light in the eyes) and HEADACHE (Continuous headache). At the time of the report, PHOTOPSIA (Flashes of light in the eyes) outcome was unknown and HEADACHE (Continuous headache) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Aug-2021, SARS-CoV-2 test: (Positive) COVID-19 test positive. On an unknown date, Angiogram: found nothing. On an unknown date, Vascular imaging: found nothing.         It was reported that the patient's physician did an MRI. He went to a cardiologist. It has been a year and the patient was still having a headache. He suffered headache anywhere in the head. He never had headache before now he was having them 2/3 times a day.  The patient tried 3 different medications to help with the headache, but it was not stopping the headache.   This case was linked to MOD-2022-645273.
Dizziness; Fever; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A patient (no qualifiers provided) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 20Sep2023 as dose number unknown, single (Lot number: HG4629) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious) with onset 20Sep2023, outcome "recovering"; PYREXIA (non-serious) with onset 20Sep2023, outcome "recovering", described as "Fever". Therapeutic measures were taken as a result of dizziness, pyrexia.  Additional information: following vaccination, the patient was feeling dizziness and with fever, took acetaminophen (TYLENOL).
I received the Moderna COVID-19 booster on 12/9/2021. On 11/27/2022, my throat felt a little bit scratchier, drier, and congested. I could sort of tell that I was coming down with something. On 11/28/2022, I woke up at 5 AM with low-grade fever and a mild headache. I did a home antigen test and got a positive result. I called my doctor's office when it opened and informed them of the positive result. They scheduled a telehealth visit with my provider for that afternoon. When we had the telehealth visit, she prescribed me Paxlovid. I began taking the Paxlovid that night and took it for the prescribed 5 days. When I woke up on 11/29/2022, my body aches and headache were gone, though I still had a low-grade fever. I also had a foul aftertaste that was left by the Paxlovid in my mouth. I self-isolated for 5 days and didn't do much other than sleep and take Paxlovid. On 12/4/2022, I took another home antigen test and got a negative result. On 12/5/2022 or 12/6/2022, my tongue had a weird greasy feeling. I messaged my doctor about it. She told me that she had never heard of that symptom occurring with COVID-19, but she told me to let her know if it didn't improve. Thankfully, though, it did resolve. At the time of this writing, I tire easily and have an occasional productive cough. Other than that, I'm fine, though.
6-8-18-pt received PNEUMOVAX 23 vaccine. 6-10-18-pt went to walk in clinic with irritation with redness-was given BACTRIM DS. Went to hospital later and was admitted. 6-11-18-pt doing better-was on IV antibiotics.
Hair loss; This is a spontaneous report received from a non-contactable consumer (patient). A 55-year-old female patient (not pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 07May2021 (at the age of 55 years old) (Batch/Lot number was not reported) as 1st dose, single dose for covid-19 immunisation. Medical history included Systemic lupus, Heart issues, Hypothyroidism. Concomitant medication received within 2 weeks of vaccination included levothyroxine. Facility where the most recent COVID-19 vaccine was administered in Pharmacy or Drug Store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced hair loss on 09May2021 12:00. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination, the patient hadn't been tested for COVID-19. The outcome of the event was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
40 y/o who is evaluated for persisting polyarthralgias following immunization series in March and May 2007. He developed disabling bilateral shoulder pain that has fluctuated in intensity between the two shoulders, hips, L>R; both knees, L>R, and a period of days when the L knee seemed visibly swollen. He has noted decreased definition in the L thigh muscle. Ankles have been painful with motion and less with simple weight bearing, although standing in full combat gear eventually causes pain. His wrists have felt tight, but improve with motion. Noteworthy is that with the exception of the L knee no joint has swelled. Joints that are painful are explicitly not warm, swollen or tender to touch.
I am pregnant and due at the end of July. Immediately following the shot my arm turned red, painful and swollen at the site of the injection. At about 4am I woke up with very rapid heartbeat which I still have possibly to a lesser degree. When I got up around 9 I experienced nausea and violently vomited twice. I have aches and pains and a throbbing migraine for the last 2 hours. My arm is still swollen and painful.
Tenderness, soreness, swollen, itchiness at injection site. Began a few days after receiving the vaccine and while tenderness is gone, redness/bruising is still visible 12 days after vaccination.
pt took 1st capsule & 5 hrs later devel diarrhea; then took 2nd capsule & 6 hrs later was vomiting;
prolonged crying inconsolably for 5 hrs spontaneous resolution; APAP was given adequate doses every 4 hrs p/vax;